U.S. Physical Therapy, Inc. (NYSE:USPH) – Equities researchers at Cantor Fitzgerald issued their FY2018 earnings estimates for shares of U.S. Physical Therapy in a research note issued on Sunday. Cantor Fitzgerald analyst J. France expects that the company will post earnings of $2.50 per share for the year. Cantor Fitzgerald has a “Overweight” rating and a $90.00 price objective on the stock.

How to Become a New Pot Stock Millionaire

A number of other equities research analysts also recently weighed in on the company. Jefferies Group set a $76.00 target price on U.S. Physical Therapy and gave the company a “hold” rating in a report on Friday, February 23rd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $82.00 price objective on the stock in a report on Saturday, January 6th. Finally, Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, March 9th. Four research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average price target of $79.40.

Shares of U.S. Physical Therapy (USPH) opened at $83.25 on Wednesday. The firm has a market capitalization of $1,075.69, a price-to-earnings ratio of 41.30, a price-to-earnings-growth ratio of 3.13 and a beta of 1.16. U.S. Physical Therapy has a twelve month low of $56.50 and a twelve month high of $87.50. The company has a quick ratio of 2.04, a current ratio of 1.95 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Thursday, March 8th. The company reported $0.49 earnings per share for the quarter, meeting the Zacks’ consensus estimate of $0.49. The firm had revenue of $109.20 million for the quarter, compared to the consensus estimate of $104.12 million. U.S. Physical Therapy had a return on equity of 13.12% and a net margin of 5.38%.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 13th. Investors of record on Wednesday, March 21st will be issued a dividend of $0.23 per share. This is an increase from U.S. Physical Therapy’s previous quarterly dividend of $0.20. The ex-dividend date of this dividend is Tuesday, March 20th. This represents a $0.92 annualized dividend and a dividend yield of 1.11%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 45.71%.

In related news, CFO Lawrance W. Mcafee sold 2,000 shares of the firm’s stock in a transaction on Monday, March 12th. The stock was sold at an average price of $86.06, for a total transaction of $172,120.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Bernard A. Harris, Jr. sold 6,000 shares of the firm’s stock in a transaction on Monday, March 12th. The shares were sold at an average price of $86.53, for a total value of $519,180.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,625 shares of company stock worth $1,295,029. 3.10% of the stock is currently owned by company insiders.

Large investors have recently made changes to their positions in the stock. SG Americas Securities LLC bought a new position in U.S. Physical Therapy during the 3rd quarter worth $170,000. UBS Asset Management Americas Inc. bought a new position in U.S. Physical Therapy during the 4th quarter worth $206,000. Ladenburg Thalmann Financial Services Inc. raised its position in U.S. Physical Therapy by 59.9% during the 3rd quarter. Ladenburg Thalmann Financial Services Inc. now owns 3,770 shares of the company’s stock worth $231,000 after purchasing an additional 1,412 shares during the last quarter. Envestnet Asset Management Inc. raised its position in U.S. Physical Therapy by 48.6% during the 4th quarter. Envestnet Asset Management Inc. now owns 3,704 shares of the company’s stock worth $267,000 after purchasing an additional 1,212 shares during the last quarter. Finally, Crossmark Global Holdings Inc. bought a new position in U.S. Physical Therapy during the 3rd quarter worth $274,000. 96.53% of the stock is owned by institutional investors and hedge funds.

ILLEGAL ACTIVITY WARNING: This story was first published by Daily Political and is owned by of Daily Political. If you are reading this story on another site, it was illegally copied and reposted in violation of U.S. & international copyright law. The correct version of this story can be read at https://www.dailypolitical.com/2018/03/14/u-s-physical-therapy-inc-expected-to-earn-fy2018-earnings-of-2-50-per-share-usph.html.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.